4//SEC Filing
Carapezzi William R JR 4
Accession 0001225208-22-003668
CIK 0000078003other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:03 PM ET
Size
12.5 KB
Accession
0001225208-22-003668
Insider Transaction Report
Form 4
PFIZER INCPFE
Carapezzi William R JR
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
2022-02-26$25.60/sh+21,193$542,541→ 87,363 total - Tax Payment
Common Stock
2022-02-26$50.64/sh−9,895$501,083→ 72,849 total - Tax Payment
Common Stock
2022-02-28$46.94/sh−1,795$84,257→ 71,054 total - Tax Payment
Common Stock
2022-02-26$47.72/sh−4,619$220,419→ 82,744 total - Exercise/Conversion
Stock Appreciation Rights
2022-02-26−21,193→ 0 totalExercise: $25.60From: 2022-02-26Exp: 2022-02-26→ Common Stock (21,193 underlying)
Holdings
- 2,915(indirect: By Rule 16b-3 Plan)
Common Stock
Footnotes (6)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F3]Price is the closing price of Pfizer common stock on February 25, 2022.
- [F4]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F5]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
- [F6]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
Documents
Issuer
PFIZER INC
CIK 0000078003
Entity typeother
Related Parties
1- filerCIK 0001295078
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:03 PM ET
- Size
- 12.5 KB